FK-506-13C-d2

FK-506-13C-d2 Suppliers list
Company Name: SIMSON PHARMA LIMITED
Tel: +91-8291074273
Email: k.das@simsonpharma.com
Products Intro: Product Name:Tacrolimus-13C,D2
CAS:1356841-89-8
Purity:96% Package:5mg;USD|10mg;USD|25mg;USD
Company Name: TargetMol Chemicals Inc.
Tel:
Email: support@targetmol.com
Products Intro: Product Name:Tacrolimus-13C-d2
CAS:1356841-89-8
Package:1mg;826USD
Company Name: Shanghai Kewel Chemical Co., Ltd.  
Tel: 021-64609169 18901607656
Email: greensnown@163.com
Products Intro: Product Name:Tacrolimus-13C,d2
CAS:1356841-89-8
Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
Company Name: Sigma-Aldrich  
Tel: 021-61415566 800-8193336
Email: orderCN@merckgroup.com
Products Intro: Product Name:Tacrolimus-13C,D2 solution
CAS:1356841-89-8
Purity:100 mug/mL in acetonitrile, certified reference material, am Package:1ML Remarks:T-066-1ML
Company Name: Artis Biotech Co. Ltd.  
Tel: 0575-18780151478 18582380095
Email: sales@artisbio.com
Products Intro: Product Name:Tacrolimus-13Cd2
CAS:1356841-89-8
Purity:98% HPLC Package:5mg 20mg 50mg 100mg 200mg 1g

FK-506-13C-d2 manufacturers

  • Tacrolimus-13C-d2
  • Tacrolimus-13C-d2 pictures
  • $826.00 / 1mg
  • 2024-10-24
  • CAS:1356841-89-8
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
  • Tacrolimus-13C,D2
  • Tacrolimus-13C,D2 pictures
  • $0.00 / 5mg
  • 2023-05-27
  • CAS:1356841-89-8
  • Min. Order: 1mg
  • Purity: 96%
  • Supply Ability: 50 mg
FK-506-13C-d2 Basic information
Product Name:FK-506-13C-d2
Synonyms:(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-13C-d2)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone;Tacrolimus-13C;Tacrolimus-13C,D2 solution;TACROLIMUS (13C, 99%;FK-506-13C,D2 (Major) (Tacrolimus) (>;(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-13C-d2)-;FK-506-13C,D2 (Major) (Tacrolimus)(>85%);D2, 98%) 100 UG/ML IN ACETONITRILE
CAS:1356841-89-8
MF:C44H67D2NO12
MW:807.039483556
EINECS:
Product Categories:
Mol File:1356841-89-8.mol
FK-506-13C-d2 Structure
FK-506-13C-d2 Chemical Properties
storage temp. -70°C
solubility Chloroform: Slightly Soluble,Methanol: Slightly Soluble
form A solid
color White to yellow
Safety Information
RIDADR UN 1648 3 / PGII
MSDS Information
FK-506-13C-d2 Usage And Synthesis
DescriptionFK-506-13C-d2 contains two deuterium atoms located on the carbon-13 bond. It is intended for use as an internal standard for the quantification of FK-506 by GC- or LC-MS. FK-506 is a potent, clinically-useful immunosuppressant in the same molecular class as cyclosporin A and rapamycin. Its mechanism of action involves the formation of a high affinity complex (Ki = 0.2 nM) with FK-506 Binding Protein 12 (FKBP12). This complex then inhibits the activity of the calcium/calmodulin-dependent protein phosphatase, calcineurin, leading to disruption of T cell activation. The physiological effects of FK-506 also include regulation of nitric oxide neurotoxicity, neurotransmitter release, and regulation of Ca2+ release via the ryanodine and inositol-(1,4,5)-trisphosphate (IP3) receptors. In the latter case, FKBP12 forms a tight complex with both ryanodine and IP3 receptors which can be disrupted by FK-506, thereby rendering the receptors “leaky” to Ca2+.
UsesA labelled immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release. A representative lot contained a distribution of 20% d-1, 40% d-2 and 20% d-3.
General DescriptionThis stable-labeled internal standard is suited for quantitation of tacrolimus by LC/MS or GC/MS for clinical toxicology, therapeutic drug monitoring, or isotope dilution methods. Tacrolimus, also known as FK-506 or fujimycin, is an immunosuppressive drug marketed as Prograf, Advagraf, and Protopic usually used to prevent rejection of organ transplants and treatment of eczema. Use of a stable-labeled analog of tacrolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
FK-506-13C-d2 Preparation Products And Raw materials
Tag:FK-506-13C-d2(1356841-89-8) Related Product Information